Kacital

Potassium citrate, the active ingredient in Kacital, is a potassium salt/alkalinizing agent presented as an oral formulation for oral administration. It supplies potassium ions and citrate, helping to correct hypokalemia, alkalinize urine to reduce renal stone formation, and treat metabolic acidosis in patients who need electrolyte supplementation.

GNH USA supplies Kacital as a licensed, GDP‑compliant international pharmaceutical supplier, sourcing the product from EU manufacturers and serving hospitals, pharmacies and clinics worldwide with quality‑assured, regulated medication, including comprehensive documentation and support for import compliance.

Kacital (potassium citrate) is used to manage electrolyte balance and urinary chemistry disorders.

- Hypokalemia: restores potassium levels in patients with low serum potassium. - Prevention of renal calculi: alkalinizes urine to reduce calcium‑based stone formation. - Metabolic acidosis: supplies citrate to buffer excess acid and correct systemic pH.

Potassium citrate is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Gastrointestinal discomfort: nausea, abdominal cramping, or mild diarrhea. - Taste alteration: a sour or metallic mouthfeel. - Hyperkalemia: elevated serum potassium, especially in patients with renal impairment. - Metabolic alkalosis: excessive bicarbonate generation leading to high blood pH.

Serious or Rare Side Effects: - Severe hyperkalemia: can cause cardiac arrhythmias and requires immediate medical attention. - Acute kidney injury: rare cases linked to excessive citrate load. - Allergic reactions: rash, itching, or swelling of the face and throat. - Metabolic acidosis worsening: paradoxical effect in very high doses.

Before prescribing Kacital, consider the following safety measures. - Renal function: assess kidney performance to avoid potassium accumulation. - Concomitant potassium‑sparing drugs: monitor serum potassium when used together. - Cardiac disease: patients with arrhythmias need close electrolyte monitoring. - Pregnancy and lactation: use only if the potential benefit outweighs risk, as data are limited. - Storage: Store at ambient temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Potassium citrate may interact with several medications; awareness helps prevent complications.

Major Interactions (Avoid): - ACE inhibitors or ARBs combined with potassium‑sparing diuretics: risk of severe hyperkalemia. - Digoxin: elevated potassium can reduce digoxin toxicity but may also mask toxicity signs.

Moderate Interactions (Monitor Closely): - Loop or thiazide diuretics: may increase potassium loss, requiring dose adjustment. - NSAIDs: can impair renal potassium excretion, raising serum levels. - Antacids containing aluminum or magnesium: may affect citrate absorption.